How much is the Apheresis Devices Market market?

The apheresis devices market market size is estimated to grow at $$ 1.59 bn in 2023. Read More

What is the growth rate of the Apheresis Devices Market market?

The growth rate of the apheresis devices market year-over-year is 8.45%. Read More

Which region held the largest market share in the Apheresis Devices Market market?

North America is the region to held the largest market share with 44% growth. Read More

Who are the key players in the Apheresis Devices Market market?

Asahi Kasei Corp., B.Braun SE, BioIVT LLC, Braun and Co. Ltd., Charles River Laboratories International Inc., Fresenius Medical Care AG and Co. KGaA, Haemonetics .... Read More

Which Segment has the largest market share in the Apheresis Devices Market market?

Product is the segment that has the largest market share in the market. Read More

Apheresis Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Mar 2024
Pages: 169
SKU: IRTNTR40157

Enjoy complimentary customisation on priority with our Enterprise License!

Apheresis Devices Market Size 2024-2028

The global apheresis devices market size is estimated to grow by USD 1.59 million, at a CAGR of 8.45% between 2023 and 2028.

Plasma products, derived from the blood of donors, serve as life-saving options for various medical conditions like trauma and disseminated intravascular coagulation (DIC). These products, including fresh-frozen plasma and solvent-treated plasma, correct deficiencies of clotting factors and are vital in treating neurological conditions and haematological disorders. Pharmaceutical companies are increasingly focusing on plasma-derived products for diverse therapeutic applications. Plasma can be collected as recovered plasma or source plasma, primarily through apheresis. The therapeutic plasma exchange process treats diseases like Guillain-Barre syndrome and Myasthenia gravis. Manufacturers in the market are developing advanced products to obtain source plasma, catering to specific disease indications. This trend of expanding indications for plasma products is expected to drive market growth during the forecast period.

What will be the Size of the Market During the Forecast Period?

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global apheresis devices market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global apheresis devices market 2018 - 2022 ($ billion)

4.2 Product Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ billion)

4.3 Application Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Application Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Product - Market share 2023-2028 (%)

6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product

6.3 Systems - Market size and forecast 2023-2028
- Exhibit 34: Chart on Systems - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Systems - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Systems - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Systems - Year-over-year growth 2023-2028 (%)

6.4 Consumables - Market size and forecast 2023-2028
- Exhibit 38: Chart on Consumables - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Consumables - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Consumables - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Consumables - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ billion)
- Exhibit 43: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Application

7.1 Market segments
- Exhibit 44: Chart on Application - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Application - Market share 2023-2028 (%)

7.2 Comparison by Application
- Exhibit 46: Chart on Comparison by Application
- Exhibit 47: Data Table on Comparison by Application

7.3 Neurological disorders - Market size and forecast 2023-2028
- Exhibit 48: Chart on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 49: Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 50: Chart on Neurological disorders - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%)

7.4 Haematological disorders - Market size and forecast 2023-2028
- Exhibit 52: Chart on Haematological disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Haematological disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Haematological disorders - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Haematological disorders - Year-over-year growth 2023-2028 (%)

7.5 Renal disorders - Market size and forecast 2023-2028
- Exhibit 56: Chart on Renal disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Renal disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Renal disorders - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Renal disorders - Year-over-year growth 2023-2028 (%)

7.6 Autoimmune disorders - Market size and forecast 2023-2028
- Exhibit 60: Chart on Autoimmune disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Autoimmune disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Autoimmune disorders - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Autoimmune disorders - Year-over-year growth 2023-2028 (%)

7.7 Market opportunity by Application
- Exhibit 64: Market opportunity by Application ($ billion)
- Exhibit 65: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2023-2028 (%)
- Exhibit 68: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 Canada - Market size and forecast 2023-2028
- Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.10 UK - Market size and forecast 2023-2028
- Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.11 China - Market size and forecast 2023-2028
- Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ billion)
- Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption

11.4 Industry risks
- Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 113: Vendors covered

12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification

12.3 Asahi Kasei Corp.
- Exhibit 115: Asahi Kasei Corp. - Overview
- Exhibit 116: Asahi Kasei Corp. - Business segments
- Exhibit 117: Asahi Kasei Corp. - Key news
- Exhibit 118: Asahi Kasei Corp. - Key offerings
- Exhibit 119: Asahi Kasei Corp. - Segment focus

12.4 B.Braun SE
- Exhibit 120: B.Braun SE - Overview
- Exhibit 121: B.Braun SE - Business segments
- Exhibit 122: B.Braun SE - Key offerings
- Exhibit 123: B.Braun SE - Segment focus

12.5 BioIVT LLC
- Exhibit 124: BioIVT LLC - Overview
- Exhibit 125: BioIVT LLC - Product / Service
- Exhibit 126: BioIVT LLC - Key news
- Exhibit 127: BioIVT LLC - Key offerings

12.6 Cerus Corp.
- Exhibit 128: Cerus Corp. - Overview
- Exhibit 129: Cerus Corp. - Product / Service
- Exhibit 130: Cerus Corp. - Key offerings

12.7 Charles River Laboratories International Inc.
- Exhibit 131: Charles River Laboratories International Inc. - Overview
- Exhibit 132: Charles River Laboratories International Inc. - Business segments
- Exhibit 133: Charles River Laboratories International Inc. - Key news
- Exhibit 134: Charles River Laboratories International Inc. - Key offerings
- Exhibit 135: Charles River Laboratories International Inc. - Segment focus

12.8 Fresenius Medical Care AG and Co. KGaA
- Exhibit 136: Fresenius Medical Care AG and Co. KGaA - Overview
- Exhibit 137: Fresenius Medical Care AG and Co. KGaA - Business segments
- Exhibit 138: Fresenius Medical Care AG and Co. KGaA - Key news
- Exhibit 139: Fresenius Medical Care AG and Co. KGaA - Key offerings
- Exhibit 140: Fresenius Medical Care AG and Co. KGaA - Segment focus

12.9 Haemonetics Corp.
- Exhibit 141: Haemonetics Corp. - Overview
- Exhibit 142: Haemonetics Corp. - Business segments
- Exhibit 143: Haemonetics Corp. - Key offerings
- Exhibit 144: Haemonetics Corp. - Segment focus

12.10 Haier Smart Home Co. Ltd.
- Exhibit 145: Haier Smart Home Co. Ltd. - Overview
- Exhibit 146: Haier Smart Home Co. Ltd. - Business segments
- Exhibit 147: Haier Smart Home Co. Ltd. - Key offerings
- Exhibit 148: Haier Smart Home Co. Ltd. - Segment focus

12.11 Kaneka Corp.
- Exhibit 149: Kaneka Corp. - Overview
- Exhibit 150: Kaneka Corp. - Business segments
- Exhibit 151: Kaneka Corp. - Key offerings
- Exhibit 152: Kaneka Corp. - Segment focus

12.12 Kawasumi Laboratories Inc.
- Exhibit 153: Kawasumi Laboratories Inc. - Overview
- Exhibit 154: Kawasumi Laboratories Inc. - Product / Service
- Exhibit 155: Kawasumi Laboratories Inc. - Key offerings

12.13 Lmb Technologie GmbH
- Exhibit 156: Lmb Technologie GmbH - Overview
- Exhibit 157: Lmb Technologie GmbH - Product / Service
- Exhibit 158: Lmb Technologie GmbH - Key offerings

12.14 Mallinckrodt Plc
- Exhibit 159: Mallinckrodt Plc - Overview
- Exhibit 160: Mallinckrodt Plc - Business segments
- Exhibit 161: Mallinckrodt Plc - Key offerings
- Exhibit 162: Mallinckrodt Plc - Segment focus

12.15 Medica S.p.A.
- Exhibit 163: Medica S.p.A. - Overview
- Exhibit 164: Medica S.p.A. - Product / Service
- Exhibit 165: Medica S.p.A. - Key offerings

12.16 Miltenyi Biotec B.V. and Co. KG
- Exhibit 166: Miltenyi Biotec B.V. and Co. KG - Overview
- Exhibit 167: Miltenyi Biotec B.V. and Co. KG - Product / Service
- Exhibit 168: Miltenyi Biotec B.V. and Co. KG - Key offerings

12.17 Nikkiso Co. Ltd.
- Exhibit 169: Nikkiso Co. Ltd. - Overview
- Exhibit 170: Nikkiso Co. Ltd. - Business segments
- Exhibit 171: Nikkiso Co. Ltd. - Key news
- Exhibit 172: Nikkiso Co. Ltd. - Key offerings
- Exhibit 173: Nikkiso Co. Ltd. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 174: Inclusions checklist
- Exhibit 175: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 176: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 177: Research methodology
- Exhibit 178: Validation techniques employed for market sizing
- Exhibit 179: Information sources